Correlation Between Enlivex Therapeutics and Arlo Technologies

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Arlo Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Arlo Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and Arlo Technologies, you can compare the effects of market volatilities on Enlivex Therapeutics and Arlo Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Arlo Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Arlo Technologies.

Diversification Opportunities for Enlivex Therapeutics and Arlo Technologies

0.22

Correlation Coefficient

Enlivex Therapeutics  Arlo Technologies

Modest diversification

The 3 months correlation between Enlivex and Arlo is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Arlo Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arlo Technologies and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Arlo Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arlo Technologies has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Arlo Technologies go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Arlo Technologies

Given the investment horizon of 90 days Enlivex Therapeutics is expected to generate 1.1 times more return on investment than Arlo Technologies. However, Enlivex Therapeutics is 1.1 times more volatile than Arlo Technologies. It trades about 0.01 of its potential returns per unit of risk. Arlo Technologies is currently generating about -0.01 per unit of risk. If you would invest  118.00  in Enlivex Therapeutics on December 19, 2024 and sell it today you would lose (4.00) from holding Enlivex Therapeutics or give up 3.39% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Enlivex Therapeutics  vs.  Arlo Technologies

Enlivex Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Enlivex Therapeutics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Arlo Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arlo Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Arlo Technologies is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Enlivex Therapeutics and Arlo Technologies

The main advantage of trading using opposite Enlivex Therapeutics and Arlo Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Arlo Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arlo Technologies will offset losses from the drop in Arlo Technologies' long position.

The idea behind Enlivex Therapeutics and Arlo Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.